Psychedelic Therapy is on the horizon. In recent years MAPS has made progress in studying the positive impacts of MDMA on PTSD. Johns Hopkins University has conducted studies on the effects of psylocibin for clinical depression. Others have written about the ceremonial uses of ayahuasca and ibogaine having a benefit for those who have struggled with substance abuse.